Landmark stroke clinical trials DAWN and DEFUSE 3 helped validate the benefits of endovascular thrombectomy (EVT) procedure in acute ischemic stroke...

ApTOLL, a neuroprotective agent, has shown promising results in the APRIL 1b/2a trial and reduced death and disability when used alongside standard...

A brain aneurysm is a weak or thin spot in the blood vessel wall, which may balloon and fill with blood. An estimated 6.5 million people in the...

In 2022, the RapidAI clinical affairs team partnered with physicians across therapeutic areas to help advance research and improve patient outcomes.